A quick test to identify urinary tract infection pathogens and antibiotic resistance
Official title: Multiplexed Assay for Point-of-Care UTI Diagnosis (ID/AMR)
Funded at Nanopathdx, INC. · NIH-11043387 · Data updated 2026-11-12
This study is working on a quick and easy test that can tell you if you have a urinary tract infection and what antibiotics will work best, all from a urine sample in just 15 minutes, so you can get the right treatment faster and feel better sooner!
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nanopathdx, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | March 1, 2024 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $964,943 |
| NIH project number | 5R44AI181154-02 |
| Project ID | NIH-11043387 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing symptoms of urinary tract infections, particularly those at risk of antibiotic resistance.
✕Less likely to help
Patients with non-infectious urinary symptoms or those who do not have a urinary tract infection may not benefit from this research.
What this research studies
This research aims to develop a rapid point-of-care diagnostic tool that can detect pathogens causing urinary tract infections (UTIs) and their antibiotic resistance markers from a urine sample in just 15 minutes. Currently, diagnosing UTIs typically involves culture-based methods that can take several days, leaving patients vulnerable to severe infections and inappropriate antibiotic treatments. The new assay will utilize a single-use cartridge and a low-cost instrument to provide immediate results, allowing for timely and targeted antibiotic therapy. This approach could significantly improve patient outcomes by reducing the time to diagnosis and treatment.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnosis of UTIs, enabling timely and appropriate antibiotic treatment.
How similar studies have gone: Other research has shown promise in developing rapid diagnostic tests for infections, indicating that this approach has potential for success.
Where this research is happening
-
Nanopathdx, INC.
Cambridge, United States Active
Researchers
- Principal investigator: Burklund, Alison — Nanopathdx, INC.
- Study coordinator: Burklund, Alison
Related research
Other NIH-funded projects on the same topics.
-
Rapid, bedside test for identifying UTI bacteria and antibiotic resistance
A quick, 15-minute point-of-care test from urine samples to identify UTI germs and key antibiotic resistance markers, helping doctors choose the right treatment sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.